Best GLP-1 apps of 2026

It depends on the job. For the brand-first take on what a GLP-1 tracker app is and when GLP AI fits (medication, scored meals, and a coach in one place), see the GLP-1 tracker app page. This page is the comparison: GLP AI for all-in-one tracking, Shotsy for a compact dose-first log, MeAgain for gamified habits, MyNetDiary when a mature food database decides it. Use the tables above for free tiers and the 11-app matrix.

Yes. GLP AI, MeAgain, Shotsy, MyNetDiary, Glapp, and Pep all offer free tiers. Free covers tracking, with a limited try of the AI coach, Meal Score, and medication chart. Premium unlocks the full versions.

Shotsy is a dose-first GLP-1 tracker: shots and pills, reminders, estimated levels, side effects, and weight. GLP AI adds a 0–100 GLP-1 Meal Score for every meal and a 24/7 AI coach grounded in your logs. Choose Shotsy for a compact medication loop; choose GLP AI when meals need to be judged for GLP-1 needs in the same place.

MeAgain centers on gamified habit formation: streaks, Journey Cards, and a virtual companion. GLP AI centers on scored feedback and answers: every meal gets a 0–100 GLP-1 Meal Score and the AI coach responds to questions grounded in your logs. Both track injections and side effects.

MyFitnessPal has the largest food database of any tracking app and works for macro logging. However, it has no medication tracking, no injection logging, and no GLP-1-specific nutritional framing. GLP-1 users who start with MyFitnessPal often add a GLP-1-specific app for the medication side.

At minimum: dose timing, injection site (for injectables), meals and protein intake, side effects, and weight. GLP AI tracks all of these in one place. The goal is to have enough data to spot patterns (like rougher days after dose increases) and to give your doctor a clear picture at each visit.

A GLP-1 Meal Score is a 0–100 rating that tells you whether a meal is suitable for a GLP-1 user, based on protein, fiber, portion balance, and nutrition quality. GLP AI calculates it from a single photo of the plate, no weighing or measuring needed. It uses letter grades (A+, A, B, C) and plain-language feedback. No other GLP-1 tracking app offers a meal scoring feature.

GLP-1 medications suppress appetite before they suppress your body's need for protein. Research on rapid weight loss shows that a meaningful share of the weight lost on GLP-1 medications can be lean muscle mass rather than fat, with estimates commonly cited in the range of 15–25% when protein intake is not actively protected — see Sources below (SURMOUNT-1 / SUSTAIN-6 and prescribing information). On a reduced appetite of 800–1,200 calories a day, every bite needs to count. GLP AI's meal scoring and 7-day meal plan are built around protecting that protein intake first.

Yes. GLP AI includes a 7-day high-protein meal plan designed specifically for GLP-1 users: 140–160g daily protein, 25–35g fiber, approximately 1,400–1,600 calories, small portions, easy-to-digest ingredients, and a protein-first structure at every meal. It is the only plan on this list built around the 0–100 GLP-1 Meal Score. MyNetDiary added dietitian-designed GLP-1 meal plans in Premium in May 2026.

Yes. The GLP-1 Meal Score tells you in real time whether a specific meal earns its place given your reduced appetite. The 24/7 AI coach answers questions like "what should I eat on shot day?" or "how do I hit my protein when I have no appetite?" grounded in your own logged data. The 7-day meal plan provides a ready-made starting point for the first week on the medication.

GLP AI places logged symptoms on the same timeline as doses and estimated medication levels, making it easier to connect symptoms to dose timing and escalation. Log the symptom when it happens, and the app surfaces the pattern alongside your dose history.

GLP AI works with any GLP-1, including Wegovy (semaglutide) and Zepbound (tirzepatide). It tracks the dose schedule, injection sites, estimated medication levels, meals, side effects, weight, and progress, with an AI coach available for questions throughout the journey.

Yes. GLP AI works with any GLP-1 regardless of whether the prescription is branded or compounded. Glapp also has specialized supply and vial math for users managing compounded doses from vials.

No GLP-1 tracking app listed here provides medical advice or replaces a licensed clinician. They are tracking and education tools. Always discuss symptoms, dose changes, and treatment decisions with your prescribing provider.

Semaglutide has a half-life of approximately 7 days, which is why Ozempic, Wegovy, and other semaglutide products are dosed weekly. Levels continue building for roughly 4 to 5 weeks after each dose change before reaching steady state. This is why appetite suppression and side effect intensity often shift in the weeks following a dose increase rather than immediately. Source: Ozempic Prescribing Information (Novo Nordisk).

Tirzepatide has a half-life of approximately 5 days, and steady state arrives roughly 2 weeks after each dose change, faster than semaglutide. Mounjaro and Zepbound are both tirzepatide and follow this profile. Source: Zepbound Prescribing Information (Eli Lilly).

Ozempic typically escalates 0.25 mg (weeks 1–4), 0.5 mg (weeks 5–8), then 1.0 mg (weeks 9 and beyond), up to a 2.0 mg maximum. Zepbound typically escalates 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, up to a 15 mg maximum, with at least 4 weeks at each step. Your prescriber sets your actual schedule, and doses should never be adjusted independently. Sources: manufacturer prescribing information for each product.

In the SURMOUNT-1 trial, participants on 15 mg tirzepatide lost a mean of 20.9% of body weight at 72 weeks, and 19.5% on the 10 mg dose. Semaglutide trials report lower but still substantial mean loss. In SUSTAIN-6, semaglutide also reduced major cardiovascular events by 26% in participants with type 2 diabetes. Individual results vary considerably. Sources: Jastreboff et al., NEJM 2022; Marso et al., NEJM 2016.

GLP AI publishes dedicated tracker pages for Ozempic, Wegovy, Mounjaro, Zepbound, Rybelsus, Saxenda, semaglutide, tirzepatide, retatrutide, and orforglipron. Each includes the dose escalation schedule for that compound, its half-life, an estimated medication level chart, and clinical trial data sourced from manufacturer prescribing information and peer-reviewed publications. Most competitor apps handle GLP-1 medications generically rather than per compound.

Yes. GLP AI works with any GLP-1 regardless of whether it is branded or compounded, and regardless of whether it came from a doctor, pharmacy, insurance plan, telehealth service, or compounding pharmacy. Glapp specializes in vial concentration and supply math for users managing compounded doses.